FdaApplication
BLA 761112
Identifiers
- fda_app_no: BLA761112
Properties
| Property | Value |
|---|---|
| applicant_name | Ablynx NV |
| application_type | BLA |
| approval_date | 2019-02-06 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CABLIVI | CAPLACIZUMAB-YHDP | 11MG | For injection |
1 product